It is feasible that these peptide regions could be responsible for interacting with PSA substrates, like semenogelin-1 and 2, or could be related to PSA acting extracellularly in the tumor microenvironment to proteolytically modify the ECM. Here, SEMG1 is linked to neoplasm.